KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TherapeuticsMD (TXMD) Tax Provisions: 2011-2025

  • TherapeuticsMD's Tax Provisions was N/A to -$32,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $272,304, marking a year-over-year change of. This contributed to the annual value of -$31,000 for FY2024, which is 27.91% up from last year.
  • Per TherapeuticsMD's latest filing, its Tax Provisions stood at -$32,000 for Q1 2025, which was up 89.33% from -$300,000 recorded in Q3 2022.
  • TherapeuticsMD's Tax Provisions' 5-year high stood at $600,000 during Q2 2022, with a 5-year trough of -$300,000 in Q3 2022.
  • Its 1-year average for Tax Provisions is -$32,000, with a median of -$32,000 in 2025.